Frank Harvey, CEO at Surescripts Community pharmacists trusted to deliver care: In 2023, pharmacists will play an integral role as part of the team managing patient care for diseases like diabetes, hypertension, or multiple comorbidities. And to support this work, I predict that we will see more activity between payers, pharmacists, the government and technology organizations to ensure that pharmacists are able to perform these important activities and be reimbursed for their work. Greg
Read More
Hypertension | High Blood Pressure | Health IT | News, Analysis
NuraLogix Unveils Telehealth Platform Performing Continuous Health/Vital Signs During Video Calls
What You Should Know: - NuraLogix, global pioneers of contactless health monitoring whose technology can take over 30 medical-grade health vitals using any video-enabled device, unveils Anura™ Telehealth, a platform that performs continuous health and vital sign measurements while on a video call. - This is the latest addition to its AnuraTM platform that uses conventional video cameras to extract facial blood flow information to accurately calculate a host of medical vitals and health
Read More
Valencell Unveils Calibration-Free, Cuffless Blood Pressure Monitor
What You Should Know: - Valencell, the company whose optical heart rate technology enabled the ability of wearables to accurately measure cardiovascular vitals during exercise, today announced plans to launch its own branded product line in the digital health sector as it concentrates efforts to bring solutions to market to manage chronic diseases. - The company’s first product candidate being showcased at CES is focused on helping people monitor and manage hypertension by combining
Read More
Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
What You Should Know: - Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis. - Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More
HLTH22: Rimidi Launches New Respiratory Module to Deliver Better Treatment
What You Should Know: - Rimidi launches its new Respiratory Module through integration with Teva Pharmaceuticals’ digital inhalers that be integrated into healthcare provider workflows, enhancing respiratory care and population health management. - This new module allows providers to comprehend the full picture of the patient's disease status both in the clinic and at home – giving clinical teams the tools they need to make personalized, predictive care decisions and improve
Read More
HLTH22: NuraLogix Researchers Announce the Capability to Assess Type 2 Diabetes and Blood Biomarker Health Issues Using Any Video-Enabled Device
What You Should Know: - Researchers at NuraLogix, a global pioneer of contactless health monitoring through its patented Transdermal Optical Imaging (TOI™) technology, have announced that it is adding the ability to perform metabolic and blood biomarker health risk assessments for various chronic conditions to its AnuraTM platform. - As a first for video-based contactless health monitoring, the new capabilities add to the existing health and wellness measurements* Anura™ can assess from a
Read More
Moving The Focus of Healthcare to Building Healthy Habits That Last
Without addressing root causes through sustained behavior modification, all results are temporary The most effective approach to preventing and treating chronic disease today focuses on the creation of healthy habits that fundamentally change behavior in a sustainable way. Smart solutions involve personalized programs based on genetic testing, nutrition, exercise, mental well-being and 1:1 personal health coaching. This combination has achieved remarkable success in both warding off chronic
Read More
Brain Health: The Next Frontier in the Fight Against Dementia
There are differing views on the value of cognitive screening of older adults in a primary care setting. Many providers point to the lack of disease-modifying treatments for Alzheimer’s Dementia and related dementias (ADRD) as a reason to not universally screen older adults for cognitive deficits. If I don’t have anything to give my patients to get better, what’s the point in revealing they might be at risk of dementia, or that they have early disease? Is dementia a ‘normal’ or ‘expected’ part
Read More
Eko Lands $2.7M NIH Grant to Train Pulmonary Hypertension AI
What You Should Know: - Eko, a digital health company applying machine learning in the fight against heart and lung disease, today announced that it was awarded a $2.7M Small Business Innovation Research (SBIR) Direct Phase II grant by the National Institutes of Health’s (NIH) Department of Health and Human Services (HHS). - The grant will fund the development of a machine learning algorithm that detects and stratifies pulmonary hypertension (PH) using phonocardiogram (PCG) and
Read More
RWJUH Opens Center for Innovation for Medical Research
What You Should Know: - Robert Wood Johnson University Hospital (RWJUH), an RWJBarnabas Health facility, and Rutgers Robert Wood Johnson Medical School (RWJMS) launched a new model for medical research and innovation today at the grand opening of its Center for Innovation, located on the main campus of the hospital. - The Center for Innovation is a partnership between RWJUH and Rutgers RWJMS to bring together clinicians, researchers and private industry to invent and develop new
Read More
